Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 6/2015

Open Access 01-06-2015 | Original Article

FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma

Authors: Simone Punt, Marjolein E. van Vliet, Vivian M. Spaans, Cornelis D. de Kroon, Gert Jan Fleuren, Arko Gorter, Ekaterina S. Jordanova

Published in: Cancer Immunology, Immunotherapy | Issue 6/2015

Login to get access

Abstract

Cervical adenocarcinoma comprises approximately 15 % of cervical cancer cases. This histological subtype has different characteristics than cervical squamous cell carcinoma, which may influence disease progression. To study whether the infiltration of T cell subpopulations was correlated with cervical adenocarcinoma patient survival, similar to squamous cell carcinoma, the tumor-infiltrating T cells, Tregs, Th17 cells and IL-17+ cell frequencies were analyzed in a cohort of cervical adenocarcinoma patients (n = 67). Intraepithelial, stromal and total cell frequencies were scored using triple immunofluorescence. The majority of Tregs were present in the tumor stroma, while other T cells and IL-17+ cells infiltrated the tumor epithelium three times more frequently. A high total number of Tregs were significantly correlated with improved disease-specific and disease-free survival (p = 0.010, p = 0.007). Within the tumor epithelium, a high T cell frequency was significantly correlated with improved disease-free survival (p = 0.034). In particular, a low number of both Tregs and IL-17+ cells were correlated with poor disease-specific survival (p = 0.007). A low number of Tregs combined with Th17 cells present were also correlated with poor survival (p = 0.018). An increased number of IL-17+ cells were significantly correlated with the absence of vaso-invasion (p = 0.001), smaller tumor size (p = 0.030) and less infiltration depth (p = 0.021). These results suggest that Tregs and IL-17+ cells represent a beneficial immune response, whereas Th17 cells might represent a poor response in cervical adenocarcinoma. This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.
Appendix
Available only for authorised users
Literature
2.
go back to reference Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004) Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 100:1035–1044. doi:10.1002/cncr.20064 PubMedCrossRef Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004) Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 100:1035–1044. doi:10.​1002/​cncr.​20064 PubMedCrossRef
7.
go back to reference Shimada M, Nishimura R, Nogawa T, Hatae M, Takehara K, Yamada H et al (2013) Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance. Mol Clin Oncol 1:780–784. doi:10.3892/mco.2013.112 PubMedCentralPubMed Shimada M, Nishimura R, Nogawa T, Hatae M, Takehara K, Yamada H et al (2013) Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance. Mol Clin Oncol 1:780–784. doi:10.​3892/​mco.​2013.​112 PubMedCentralPubMed
8.
go back to reference Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912–917PubMed Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912–917PubMed
11.
go back to reference Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ (2005) Cervical cancer in the Netherlands 1989–1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113:1005–1009. doi:10.1002/ijc.20678 PubMedCrossRef Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ (2005) Cervical cancer in the Netherlands 1989–1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113:1005–1009. doi:10.​1002/​ijc.​20678 PubMedCrossRef
12.
go back to reference Sherman ME, Wang SS, Carreon J, Devesa SS (2005) Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 103:1258–1264. doi:10.1002/cncr.20877 PubMedCrossRef Sherman ME, Wang SS, Carreon J, Devesa SS (2005) Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 103:1258–1264. doi:10.​1002/​cncr.​20877 PubMedCrossRef
23.
go back to reference Adurthi S, Mukherjee G, Krishnamurthy H, Sudhir K, Bafna UD, Umadevi K et al (2012) Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer 22:1130–1137. doi:10.1097/IGC.0b013e318262aa53 PubMedCrossRef Adurthi S, Mukherjee G, Krishnamurthy H, Sudhir K, Bafna UD, Umadevi K et al (2012) Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells. Int J Gynecol Cancer 22:1130–1137. doi:10.​1097/​IGC.​0b013e318262aa53​ PubMedCrossRef
24.
go back to reference Santin AD, Hermonat PL, Hiserodt JC, Fruehauf J, Schranz V, Barclay D et al (1997) Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 64:477–480. doi:10.1006/gyno.1996.4579 PubMedCrossRef Santin AD, Hermonat PL, Hiserodt JC, Fruehauf J, Schranz V, Barclay D et al (1997) Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 64:477–480. doi:10.​1006/​gyno.​1996.​4579 PubMedCrossRef
25.
go back to reference Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028–2035. doi:10.1158/1078-0432.CCR-07-4554 PubMedCrossRef Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028–2035. doi:10.​1158/​1078-0432.​CCR-07-4554 PubMedCrossRef
26.
go back to reference Punt S, Fleuren GJ, Kritikou E, Lubberts E, Trimbos JB, Jordanova ES et al (2015) Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer. OncoImmunology 4:e984539. doi:10.4161/2162402X.2014.984539 PubMedCrossRef Punt S, Fleuren GJ, Kritikou E, Lubberts E, Trimbos JB, Jordanova ES et al (2015) Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer. OncoImmunology 4:e984539. doi:10.​4161/​2162402X.​2014.​984539 PubMedCrossRef
28.
go back to reference Wilbur DC, Mikami Y, Colgan TJ, Park KJ, Ferenczy AS, Ronnett BM et al (2014) Tumours of the uterine cervix. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs, 4th edn. IARC, Lyon, pp 183–189 Wilbur DC, Mikami Y, Colgan TJ, Park KJ, Ferenczy AS, Ronnett BM et al (2014) Tumours of the uterine cervix. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs, 4th edn. IARC, Lyon, pp 183–189
29.
go back to reference Shah W, Yan X, Jing L, Zhou Y, Chen H, Wang Y (2011) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol 8:59–66. doi:10.1038/cmi.2010.56 PubMedCentralPubMedCrossRef Shah W, Yan X, Jing L, Zhou Y, Chen H, Wang Y (2011) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell Mol Immunol 8:59–66. doi:10.​1038/​cmi.​2010.​56 PubMedCentralPubMedCrossRef
30.
go back to reference Sayour EJ, McLendon P, McLendon R, De LG, Reynolds R, Kresak J et al (2015) Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunol Immunother. doi:10.1007/s00262-014-1651-7 PubMed Sayour EJ, McLendon P, McLendon R, De LG, Reynolds R, Kresak J et al (2015) Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunol Immunother. doi:10.​1007/​s00262-014-1651-7 PubMed
31.
go back to reference Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593. doi:10.1200/JCO.2006.09.4565 PubMedCrossRef Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593. doi:10.​1200/​JCO.​2006.​09.​4565 PubMedCrossRef
32.
go back to reference Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.1038/nm1093 PubMedCrossRef Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.​1038/​nm1093 PubMedCrossRef
33.
35.
go back to reference Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77:918–925. doi:10.1111/j.1365-2265.2012.04482.x CrossRef Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S et al (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77:918–925. doi:10.​1111/​j.​1365-2265.​2012.​04482.​x CrossRef
45.
Metadata
Title
FoxP3+ and IL-17+ cells are correlated with improved prognosis in cervical adenocarcinoma
Authors
Simone Punt
Marjolein E. van Vliet
Vivian M. Spaans
Cornelis D. de Kroon
Gert Jan Fleuren
Arko Gorter
Ekaterina S. Jordanova
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 6/2015
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-015-1678-4

Other articles of this Issue 6/2015

Cancer Immunology, Immunotherapy 6/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine